Birchview Capital’s Dermira, Inc. DERM Stock Holding History

Birchview Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-80,000	Closed	-$1.21M	–	57
2019 Q4	$1.21M	Sell	80,000 -40,000	-33%	-$345K	0.88%	19
2019 Q3	$767K	Hold	120,000	–	–	0.51%	18
2019 Q2	$1.15M	Buy	120,000 +100,000	+500%	+$1.08M	0.7%	16
2019 Q1	$271K	Buy	+20,000	New	+$167K	0.17%	42

Birchview Capital's DERM Position: Q1 2020 in Review

Birchview Capital sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 80,000 shares — an estimated $1.21M sold.

Birchview Capital first reported a position in DERM in Q1 2019 and held it in 4 quarters. The position peaked at $1.21M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Birchview Capital reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Birchview Capital sold 80,000 Dermira, Inc. shares in Q1 2020, an estimated $1.21M.
Birchview Capital first reported a position in Dermira, Inc. in Q1 2019 and held it in 4 quarters.
Birchview Capital's Dermira, Inc. position peaked at $1.21M in Q4 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Birchview Capital's 13F filing for Q1 2020, filed 12 May 2020.